SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) Short Interest Down 21.2% in February

SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) was the target of a significant drop in short interest in the month of February. As of February 27th, there was short interest totaling 616,003 shares, a drop of 21.2% from the February 12th total of 781,872 shares. Based on an average daily trading volume, of 80,740 shares, the short-interest ratio is currently 7.6 days. Approximately 11.8% of the shares of the company are short sold. Approximately 11.8% of the shares of the company are short sold. Based on an average daily trading volume, of 80,740 shares, the short-interest ratio is currently 7.6 days.

Institutional Trading of SPDR S&P Pharmaceuticals ETF

Several institutional investors have recently modified their holdings of the company. Advisory Services Network LLC bought a new stake in shares of SPDR S&P Pharmaceuticals ETF during the third quarter valued at approximately $34,000. Team Financial Group LLC bought a new position in SPDR S&P Pharmaceuticals ETF in the fourth quarter worth $56,000. Kestra Advisory Services LLC acquired a new stake in SPDR S&P Pharmaceuticals ETF during the fourth quarter worth $151,000. Rockport Wealth LLC bought a new stake in SPDR S&P Pharmaceuticals ETF in the 2nd quarter valued at $203,000. Finally, Vista Investment Management acquired a new position in shares of SPDR S&P Pharmaceuticals ETF in the 4th quarter valued at $223,000.

SPDR S&P Pharmaceuticals ETF Trading Down 0.7%

XPH traded down $0.39 on Friday, hitting $53.25. 27,500 shares of the stock traded hands, compared to its average volume of 117,510. SPDR S&P Pharmaceuticals ETF has a 52 week low of $35.22 and a 52 week high of $58.84. The firm has a market capitalization of $276.90 million, a PE ratio of 14.28 and a beta of 0.60. The business has a fifty day moving average price of $56.40 and a two-hundred day moving average price of $52.70.

SPDR S&P Pharmaceuticals ETF Company Profile

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.